These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 853069)

  • 41. Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.
    J Pharmacokinet Biopharm; 1974 Oct; 2(5):433-66. PubMed ID: 4452945
    [No Abstract]   [Full Text] [Related]  

  • 42. Editorial: Drug costs and drug quality.
    Lasagna L
    Ann Intern Med; 1974 Aug; 81(2):261-2. PubMed ID: 4843580
    [No Abstract]   [Full Text] [Related]  

  • 43. The importance and challenges of "mutual recognition".
    Merrill RA
    Seton Hall Law Rev; 1998; 29(2):736-55. PubMed ID: 10569829
    [No Abstract]   [Full Text] [Related]  

  • 44. Assuring total drug quality.
    Simmons HE
    J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621
    [No Abstract]   [Full Text] [Related]  

  • 45. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

  • 46. Assuring the quality of the nation's drugs. Interview by William E. Small.
    Michels D
    Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377
    [No Abstract]   [Full Text] [Related]  

  • 47. Hormone-containing cosmetic preparations.
    Lober CW
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):827-8. PubMed ID: 3711386
    [No Abstract]   [Full Text] [Related]  

  • 48. Negotiating reality: the construction of enforceable pharmaceutical standards.
    Parrish RH
    Food Drug Law J; 2002; 57(3):457-74. PubMed ID: 12710406
    [No Abstract]   [Full Text] [Related]  

  • 49. The responsibility of FDA to the livestock industry and the consumer. VI. Product stability and labeling for animal drugs and other feed additives.
    Knight WM; Gable DA; Golden RG
    J Anim Sci; 1973 Jul; 37(1):223-5. PubMed ID: 4720864
    [No Abstract]   [Full Text] [Related]  

  • 50. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 51. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 52. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The dermatologist, the cosmetic chemist, and the new law.
    Brauer EW
    J Med Soc N J; 1965 Oct; 62(10):489-91. PubMed ID: 5213164
    [No Abstract]   [Full Text] [Related]  

  • 54. 'Cosmeceuticals'. Of men, science and laws….
    Saint-Leger D
    Int J Cosmet Sci; 2012 Oct; 34(5):396-401. PubMed ID: 22827169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 56. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 57. [Theoretical and practical aspects of statistic sampling and related norms of acceptance].
    Mattei A; Pietra E
    Boll Chim Farm; 1968 May; 107(5):287-95. PubMed ID: 5721540
    [No Abstract]   [Full Text] [Related]  

  • 58. Quality assurance for medical products: unified program for all federal agencies.
    Flaherty FJ
    Hosp Formul; 1976 Dec; 11(12):669, 674, 679. PubMed ID: 1028796
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug Policy in the Real World.
    Pullen LC
    Am J Transplant; 2019 Nov; 19(11):2963-2964. PubMed ID: 31742915
    [No Abstract]   [Full Text] [Related]  

  • 60. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories.
    Tetzlaff RF
    J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.